The two main beta receptors that are targeted by beta blockers are the beta 1 receptor and the beta 2 receptor. A large number of beta 1 receptors are present on the heart and kidney cells ...

GLP-1 agonists, a class of medication typically used ... and the toxic effects of Alzheimer’s biomarkers amyloid-beta and tau, and improving how the brain’s nerve cells communicate.” ...

Diabetic patients treated with GLP-1 receptor agonists (GLP-1RAs ... and the need for first-line treatments for glaucoma (including beta-blockers, prostaglandin analogs, brimonidine, brinzolamide ...

This is in regard to the development of LPA1R agonist LTSE-2578 for the treatment of patients with IPF as well. A phase 1 randomized study for this program was initiated in June 2024 and is ongoing.

Glucagon-like peptide-1 (GLP-1) agonist drugs have been prescribed for ... glucagon binds to a specific receptor on the surface of beta cells in the pancreas, causing them to release insulin ...

Columnist Jen Cueva talks with her friend Lynda Pinto, who has PH, about Lynda's experience with GLP-1 agonist medications.

GLP-1, and glucagon Receptors, improves markers of pancreatic beta-cell function and insulin sensitivity" ADA 2024; 266-OR.

It may also hamper their survival. To investigate whether DYRK1A inhibitor harmine and the GLP-1 agonist exendin-4 support beta cell health, the scientists turned to a mouse model. They ...